GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PharmChem Inc (OTCPK:PCHM) » Definitions » COGS-to-Revenue

PharmChem (PharmChem) COGS-to-Revenue : 0.34 (As of Sep. 2023)


View and export this data going back to 2003. Start your Free Trial

What is PharmChem COGS-to-Revenue?

PharmChem's Cost of Goods Sold for the three months ended in Sep. 2023 was $0.53 Mil. Its Revenue for the three months ended in Sep. 2023 was $1.56 Mil.

PharmChem's COGS to Revenue for the three months ended in Sep. 2023 was 0.34.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. PharmChem's Gross Margin % for the three months ended in Sep. 2023 was 66.18%.


PharmChem COGS-to-Revenue Historical Data

The historical data trend for PharmChem's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmChem COGS-to-Revenue Chart

PharmChem Annual Data
Trend Dec93 Dec94 Dec95 Dec96 Dec97 Dec98 Dec99 Dec00 Dec01 Dec02
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 0.71 0.74 0.89 0.76

PharmChem Quarterly Data
Jun99 Sep99 Dec99 Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Sep22 Sep23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 0.78 0.76 0.35 0.34

PharmChem COGS-to-Revenue Calculation

PharmChem's COGS to Revenue for the fiscal year that ended in Dec. 2002 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=23.013 / 30.085
=0.76

PharmChem's COGS to Revenue for the quarter that ended in Sep. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.529 / 1.564
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmChem  (OTCPK:PCHM) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

PharmChem's Gross Margin % for the three months ended in Sep. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.529 / 1.564
=66.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


PharmChem COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of PharmChem's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmChem (PharmChem) Business Description

Traded in Other Exchanges
N/A
Address
2411 E. Loop 820 N, Fort Worth, TX, USA, 76118
PharmChem Inc is engaged in selling and distributing of the PharmChek Sweat Patch Device. PharmChek is a system that uses sweat to detect the presence of illegal drugs. It consists of a transparent polyurethane outer covering, a small absorbent pad, and a release liner. Geographically the activities are carried out throughout the United States.
Executives
Alto Investors Palo 10 percent owner 470 UNIVERSITY AVENUE, PALO ALTO CA 94301
Micro Cap Partners Lp 10 percent owner

PharmChem (PharmChem) Headlines

From GuruFocus

PharmChem (PCHM) Announces Response To Opposition

By PRNewswire PRNewswire 08-11-2021